Search

everythinglearnresearchcommunity

for

Search:↓

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Hair, teeth, and mammary glands develop similarly at first but use different genes later.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

A new gene, JMJD1C, may affect testosterone levels in men.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Both mouse and rat models are effective for testing alopecia areata treatments.

Wnt, Eda, and Shh pathways are crucial for different stages of sweat gland development in mice.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Blocking a specific protein signal can make hair grow on mouse nipples.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Adrenal disorders can cause lasting brain and behavior issues in children.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Reproductive factors can increase hypertension risk and affect cardiovascular health.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Mutations in certain receptors can cause diseases and offer new treatment options.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

Adrenal gland disease is common in ferrets and causes hair loss and other symptoms.